Dan Schelfaut
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dan Schelfaut has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Marc Vanderheyden
Cardiovascular Center, OLV Hospital, Aalst, Belgium
2 shared publications Andrej Iring
Powerful Medical , Bratislavska 81/37, 931 01 Samorin , Slovakia
1 shared publicationAnthony Demolder
Powerful Medical , Bratislavska 81/37, 931 01 Samorin , Slovakia
1 shared publicationAttilio Leone
Department of Advanced Biomedical Sciences, University of Naples Federico II , C.so Umberto I, 40, 80138 Naples , Italy
1 shared publication- Birgit Decommer
Cardiovascular Center Aalst, OLV Clinic Aalst , Moorselbaan 164, 9300 Aalst , Belgium
1 shared publication Boris Vavrik
Powerful Medical , Bratislavska 81/37, 931 01 Samorin , Slovakia
1 shared publication
Latest Publications
- 4 May 2025
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 80 (3) , 35-43
Barriers to guideline implementation in intermediate- and high-risk Pulmonary Embolism: insights from a real-world cohort study
Pulmonary embolism (PE) presents significant challenges due to its wide clinical spectrum, associated right ventricular failure, and high mortality rates. Despite guideline recommendations for systemic thrombolysis in high-risk PE, its implementation remains suboptimal due to safety concerns. This study investigates barriers to guideline implementation in treating intermediate- and high-risk PE and assesses catheter-based thrombectomy (CBT) as an alternative treatment. A single centre retrospective cohort study analyzed medical records of all PE-diagnoses between January 2022 and June 2023 . Patients with central, lobar, or segmental PE and Pulmonary Embolism Severity Index scores of III - V were included. A subgroup of patients received CBT. Data on patient characteristics, treatment, outcomes, and eligibility for CBT were collected. Of the 124 intermediate- and high-risk patients, thrombolysis was administered to only 17% of high-risk patients. Within the conventional treatment group, barriers to thrombolysis included contra-indications in 72% of intermediate-risk and 80% of high-risk patients, leaving a significant number eligible for CBT. Additionally, 20% of high-risk PE patients who did not received thrombolysis had no contra-indications and should have been treated with thrombolysis. In-hospital mortality was 50% among high-risk patients. Eleven patients received CBT, with no mortality at 30 days. Guideline-recommended thrombolysis is underutilized in high-risk PE, due to safety concerns and contra-indications. CBT demonstrates a promising alternative with a favourable safety profile and low mortality rates, highlighting the need for prospective studies. Multidisciplinary approaches, such as Pulmonary Embolism Response Teams, may help to standardize care and to improve outcomes.
- 4 May 2025
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 80 (3) , 35-43
Barriers to guideline implementation in intermediate- and high-risk Pulmonary Embolism: insights from a real-world cohort study
Pulmonary embolism (PE) presents significant challenges due to its wide clinical spectrum, associated right ventricular failure, and high mortality rates. Despite guideline recommendations for systemic thrombolysis in high-risk PE, its implementation remains suboptimal due to safety concerns. This study investigates barriers to guideline implementation in treating intermediate- and high-risk PE and assesses catheter-based thrombectomy (CBT) as an alternative treatment. A single centre retrospective cohort study analyzed medical records of all PE-diagnoses between January 2022 and June 2023 . Patients with central, lobar, or segmental PE and Pulmonary Embolism Severity Index scores of III - V were included. A subgroup of patients received CBT. Data on patient characteristics, treatment, outcomes, and eligibility for CBT were collected. Of the 124 intermediate- and high-risk patients, thrombolysis was administered to only 17% of high-risk patients. Within the conventional treatment group, barriers to thrombolysis included contra-indications in 72% of intermediate-risk and 80% of high-risk patients, leaving a significant number eligible for CBT. Additionally, 20% of high-risk PE patients who did not received thrombolysis had no contra-indications and should have been treated with thrombolysis. In-hospital mortality was 50% among high-risk patients. Eleven patients received CBT, with no mortality at 30 days. Guideline-recommended thrombolysis is underutilized in high-risk PE, due to safety concerns and contra-indications. CBT demonstrates a promising alternative with a favourable safety profile and low mortality rates, highlighting the need for prospective studies. Multidisciplinary approaches, such as Pulmonary Embolism Response Teams, may help to standardize care and to improve outcomes.
- Top Cited PapersOpen Access
- 28 November 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 5 (2) , 123-133
International evaluation of an artificial intelligence–powered electrocardiogram model detecting acute coronary occlusion myocardial infarction
Aims: A majority of acute coronary syndromes (ACS) present without typical ST elevation. One-third of non–ST-elevation myocardial infarction (NSTEMI) patients have an acutely occluded culprit coronary artery [occlusion myocardial infarction (OMI)], leading to poor outcomes due to delayed identification and invasive management. In this study, we sought to develop a versatile artificial intelligence (AI) model detecting acute OMI on single-standard 12-lead electrocardiograms (ECGs) and compare its performance with existing state-of-the-art diagnostic criteria. Methods and results: An AI model was developed using 18 616 ECGs from 10 543 patients with suspected ACS from an international database with clinically validated outcomes. The model was evaluated in an international cohort and compared with STEMI criteria and ECG experts in detecting OMI. The primary outcome of OMI was an acutely occluded or flow-limiting culprit artery requiring emergent revascularization. In the overall test set of 3254 ECGs from 2222 patients (age 62 ± 14 years, 67% males, 21.6% OMI), the AI model achieved an area under the curve of 0.938 [95% confidence interval (CI): 0.924–0.951] in identifying the primary OMI outcome, with superior performance [accuracy 90.9% (95% CI: 89.7–92.0), sensitivity 80.6% (95% CI: 76.8–84.0), and specificity 93.7 (95% CI: 92.6–94.8)] compared with STEMI criteria [accuracy 83.6% (95% CI: 82.1–85.1), sensitivity 32.5% (95% CI: 28.4–36.6), and specificity 97.7% (95% CI: 97.0–98.3)] and with similar performance compared with ECG experts [accuracy 90.8% (95% CI: 89.5–91.9), sensitivity 73.0% (95% CI: 68.7–77.0), and specificity 95.7% (95% CI: 94.7–96.6)]. Conclusion: The present novel ECG AI model demonstrates superior accuracy to detect acute OMI when compared with STEMI criteria. This suggests its potential to improve ACS triage, ensuring appropriate and timely referral for immediate revascularization.
- 28 November 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 5 (2) , 123-133
Top Cited PapersOpen AccessInternational evaluation of an artificial intelligence–powered electrocardiogram model detecting acute coronary occlusion myocardial infarction
Aims: A majority of acute coronary syndromes (ACS) present without typical ST elevation. One-third of non–ST-elevation myocardial infarction (NSTEMI) patients have an acutely occluded culprit coronary artery [occlusion myocardial infarction (OMI)], leading to poor outcomes due to delayed identification and invasive management. In this study, we sought to develop a versatile artificial intelligence (AI) model detecting acute OMI on single-standard 12-lead electrocardiograms (ECGs) and compare its performance with existing state-of-the-art diagnostic criteria. Methods and results: An AI model was developed using 18 616 ECGs from 10 543 patients with suspected ACS from an international database with clinically validated outcomes. The model was evaluated in an international cohort and compared with STEMI criteria and ECG experts in detecting OMI. The primary outcome of OMI was an acutely occluded or flow-limiting culprit artery requiring emergent revascularization. In the overall test set of 3254 ECGs from 2222 patients (age 62 ± 14 years, 67% males, 21.6% OMI), the AI model achieved an area under the curve of 0.938 [95% confidence interval (CI): 0.924–0.951] in identifying the primary OMI outcome, with superior performance [accuracy 90.9% (95% CI: 89.7–92.0), sensitivity 80.6% (95% CI: 76.8–84.0), and specificity 93.7 (95% CI: 92.6–94.8)] compared with STEMI criteria [accuracy 83.6% (95% CI: 82.1–85.1), sensitivity 32.5% (95% CI: 28.4–36.6), and specificity 97.7% (95% CI: 97.0–98.3)] and with similar performance compared with ECG experts [accuracy 90.8% (95% CI: 89.5–91.9), sensitivity 73.0% (95% CI: 68.7–77.0), and specificity 95.7% (95% CI: 94.7–96.6)]. Conclusion: The present novel ECG AI model demonstrates superior accuracy to detect acute OMI when compared with STEMI criteria. This suggests its potential to improve ACS triage, ensuring appropriate and timely referral for immediate revascularization.
- 20 October 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 25 (3) , e105
Recurrent patch dehiscence of left ventricular aneurysm, an unexpected cause
Matthias Verbesselt, Birgit Decommer, Dan Schelfaut, Filip Casselman, Frank Van Praet, Guy Van Camp; Recurrent patch dehiscence of left ventricular aneurysm, an
- 20 October 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 25 (3) , e105
Recurrent patch dehiscence of left ventricular aneurysm, an unexpected cause
Matthias Verbesselt, Birgit Decommer, Dan Schelfaut, Filip Casselman, Frank Van Praet, Guy Van Camp; Recurrent patch dehiscence of left ventricular aneurysm, an